Written by Aisha Saleem, Pharmacist & Health Writer at PharmaHealths.com
Last Updated: July 2026
When one treatment isn’t delivering enough, the instinct is often to assume it’s the wrong treatment. In depression care, that assumption leads to an enormous amount of unnecessary switching, from one antidepressant to another, from medication to therapy and back again, without ever asking whether combining approaches might be the more effective strategy.
Combination treatment for depression is not a last resort. For a significant proportion of patients, it is precisely what the clinical evidence recommends. But combining treatments carries real considerations around safety, interactions, and sequencing that matter enormously in practice. Understanding when combination makes sense, what the evidence supports, and what the risks are gives you the foundation to have a much more productive conversation with your prescriber.
What Does Combining Depression Treatments Actually Mean?
Combining depression treatments refers to using two or more evidence-based interventions simultaneously rather than relying on a single approach alone.
This can mean combining two medications, known as pharmacological augmentation, or combining medication with a psychological therapy, a neurostimulation treatment such as TMS, or structured lifestyle interventions. Each of these combinations has a distinct evidence base and a distinct rationale, and they are not interchangeable. The right combination depends on the clinical picture, what has already been tried, and what is practically accessible to the patient.
The clinical rationale for combination rather than sequential switching is straightforward. Depression is rarely a single system problem. It involves disrupted monoamine signaling, altered neuroplasticity, HPA axis dysregulation, and in many patients’ neuroinflammation simultaneously. In simpler terms, mood chemicals, stress hormones, and the brain’s ability to adapt are all affected at the same time. A single medication targeting one pathway may produce a partial response, and adding a second intervention targeting a complementary mechanism can produce the fuller response that one alone could not.
Can You Take Two Antidepressants Together?
Yes, combining two antidepressants is a recognized and evidence supported clinical strategy, but it is typically best initiated or supervised by a psychiatrist rather than started without specialist input.
The most widely used pharmacological augmentation strategies include adding mirtazapine to an SSRI or SNRI, a combination sometimes called California Rocket Fuel in clinical shorthand, which targets serotonin, noradrenaline, and histamine pathways simultaneously. A review published in the Journal of Clinical Psychiatry found this combination consistently produced higher response rates than either drug used alone in patients with partial response to an initial antidepressant.
Adding an atypical antipsychotic such as quetiapine or aripiprazole at low doses to an existing antidepressant is another well-established augmentation strategy. These agents act on dopamine and additional serotonin receptor subtypes that standard antidepressants do not engage. NICE guidance on depression specifically references atypical antipsychotic augmentation as an option for patients who have not responded adequately to an optimized antidepressant dose.
Lithium augmentation has one of the longest evidence histories of any combination strategy in psychiatry. Bauer et al. (2014), in a systematic review published in the International Journal of Neuropsychopharmacology, confirmed that adding lithium to an antidepressant produced meaningful improvement in treatment-resistant patients, though it requires regular blood monitoring for lithium levels and renal function.
The key safety consideration across all pharmacological combinations is serotonin syndrome, a potentially serious condition that occurs when serotonergic activity becomes dangerously elevated. The Medicines and Healthcare products Regulatory Agency advises that combining serotonergic medications requires careful prescriber oversight, and patients should be counselled to recognize early symptoms including agitation, tremor, rapid heart rate, and elevated temperature.
Can You Combine Antidepressants with Psychological Therapy?
Combining antidepressants with psychological therapy, particularly Cognitive Behavioral Therapy (CBT), is one of the most robustly evidenced strategies in depression treatment and should be considered a first line combination rather than a fallback.
Cuijpers et al. (2014), in a landmark meta-analysis published in JAMA Psychiatry, found that combining psychotherapy with antidepressant medication produced significantly better outcomes than either treatment used alone across patients with moderate to severe depression, with the benefit of combination most pronounced in patients with more severe or recurrent presentations.
The mechanistic logic is compelling. Medication modulates neurochemistry and supports the neuroplastic changes that underpin recovery. Psychological therapy directly addresses the cognitive patterns, behavioral withdrawal, and emotional processing difficulties that medication cannot reach. These are genuinely complementary rather than redundant approaches.
Mindfulness Based Cognitive Therapy (MBCT) in particular has a strong evidence base alongside medication. NICE recommends MBCT specifically for patients with three or more depressive episodes, both as a relapse prevention strategy and as an active treatment adjunct. Combining MBCT with antidepressants is not only safe, it is clinically encouraged in recurrent depression.
Can You Do TMS Therapy While on Antidepressants?
Yes, TMS is routinely used alongside antidepressant medication and there is no pharmacological interaction between the two.
George et al. (2010), in a large multicenter trial published in Brain Stimulation, found that TMS delivered significant additional benefit in patients who had not achieved remission on antidepressants alone, with most participants maintaining their medication during the TMS course. In the majority of clinical trials establishing TMS efficacy, participants continued their existing antidepressants throughout the treatment course. Stopping an antidepressant before starting TMS is not standard practice and is not recommended without a specific clinical reason.
The practical consideration is that TMS works on a completely different biological mechanism, targeting cortical neuroplasticity through magnetic stimulation of the prefrontal cortex rather than modulating neurotransmitter levels pharmacologically. This is precisely why the combination is clinically rational rather than redundant.
Can You Take Ketamine or Esketamine While on an Antidepressant?
Ketamine and esketamine can be used alongside antidepressants in most cases, but this requires careful clinical assessment rather than a straightforward yes.
Popova et al. (2019), in a pivotal clinical trial published in the New England Journal of Medicine that led to esketamine’s NICE approval, reported that esketamine was administered alongside a newly initiated oral antidepressant, and this combination approach, not ketamine alone, was what was evaluated and approved. This means the licensed use of esketamine already assumes concurrent antidepressant therapy in most patients.
The primary safety consideration is the theoretical serotonin syndrome risk when ketamine is combined with highly serotonergic antidepressants, though this risk at therapeutic doses is considered low. MAOIs, a class of antidepressants rarely used today but occasionally encountered in complex cases, are an important exception and should not be combined with ketamine. Any ketamine or esketamine treatment should be initiated and supervised by a specialist team who have reviewed the full medication history.
Are Lifestyle Interventions Safe to Combine with Antidepressants?
Lifestyle interventions including regular aerobic exercise, sleep optimization, anti-inflammatory dietary changes, and mindfulness practice are not only safe to combine with antidepressants, the evidence suggests they actively enhance medication response.
Kvam et al. (2016), in a meta-analysis published in JAMA Psychiatry, confirmed that structured aerobic exercise produced significant antidepressant effects through mechanisms that overlap with and complement pharmacological treatment, including upregulation of BDNF and modulation of HPA axis activity. These are additive effects, exercise and antidepressants working on shared biological pathways simultaneously rather than competing.
One interaction worth flagging explicitly is St John’s Wort, an herbal supplement commonly self-prescribed for low mood. St John’s Wort induces liver enzymes that significantly alter the metabolism of many antidepressants, reducing their plasma levels and effectiveness. The MHRA has issued specific guidance warning against combining St John’s Wort with SSRIs, SNRIs, or any other serotonergic medication due to both pharmacokinetic interaction and serotonin syndrome risk. This is a combination to avoid.
How Does a Psychiatrist Decide Whether to Combine or Switch?
The decision between augmenting an existing treatment and switching to something different depends on several clinical factors, and getting this right is one of the most important decisions in managing difficult to treat depression.
If a patient has had a clear partial response to their current antidepressant, meaning some improvement but not full remission, augmentation is generally preferred over switching because it preserves whatever benefit has been achieved while adding a complementary mechanism. For example, a patient who has improved mood on an SSRI but continues to struggle with sleep or appetite may benefit from adding mirtazapine rather than switching entirely. Switching makes more clinical sense when there has been no meaningful response at all, when side effects are driving discontinuation, or when a diagnostic reassessment has identified a different clinical picture that warrants a different pharmacological approach.
The British Association for Psychopharmacology and other international clinical guidelines on treating depressive disorders outline this decision framework in detail and are widely used as standard references by prescribers managing treatment resistant presentations. If you are in a situation where your doctor is simply switching you from one antidepressant to another without a structured rationale, asking for a psychiatric referral to review combination treatment options is entirely appropriate.
FAQs
Q1. Can you take two antidepressants at the same time?
Yes, combining two antidepressants is a recognized clinical strategy called pharmacological augmentation. Common combinations include adding mirtazapine to an SSRI, or adding a low dose atypical antipsychotic to an existing antidepressant. These combinations should always be directed by a psychiatrist rather than initiated without specialist input, due to interaction risks including serotonin syndrome.
Q2. What is augmentation therapy for depression?
Augmentation therapy means adding a second treatment to an existing one that has produced only a partial response, rather than abandoning the first treatment entirely. In depression, this typically means adding a second medication, a psychological therapy, or a neurostimulation treatment like TMS. The rationale is that depression involves multiple biological systems simultaneously, and combination approaches address more of them at once.
Q3. Can you do TMS therapy while still taking antidepressants?
Yes, and this is standard practice. The majority of TMS clinical trials were conducted in patients who remained on their antidepressants throughout. TMS works through a completely different mechanism, cortical magnetic stimulation rather than neurotransmitter modulation, so there is no pharmacological interaction. Stopping your antidepressant before starting TMS is not recommended without a specific clinical reason.
Q4. Can you combine ketamine infusions with an antidepressant?
In most cases yes, and the licensed use of esketamine already assumes concurrent antidepressant therapy. The main exception is MAOIs, which should not be combined with ketamine. Any ketamine or esketamine treatment must be supervised by a specialist team who review your full medication history before initiating treatment.
Q5. Does combining therapy and medication work better than either alone?
Yes, consistently so. A large meta-analysis published in JAMA Psychiatry found that combining psychotherapy with antidepressants produced significantly better outcomes than either treatment alone, particularly in moderate to severe depression. Medication and therapy work on different but complementary mechanisms, one modulating neurochemistry, the other addressing cognitive and behavioral patterns, which is precisely why the combination outperforms either approach individually.
Q6. Is St John’s Wort safe to take with antidepressants?
No. St John’s Wort is not safe to combine with SSRIs, SNRIs, or most other antidepressants. It induces liver enzymes that reduce the effectiveness of many medications, and when combined with serotonergic antidepressants it raises the risk of serotonin syndrome. The MHRA has issued specific guidance on this interaction. Always tell your prescriber or pharmacist if you are taking any herbal supplements alongside prescription medication.
Q7. How does a psychiatrist decide whether to add a treatment or switch?
The key factor is whether there has been a partial response to the current treatment. If some improvement has occurred but remission has not been achieved, augmentation is generally preferred because it preserves the existing benefit while adding a new mechanism. If there has been no meaningful response at all, switching may be more appropriate. A psychiatrist will also consider side effect profile, diagnostic accuracy, and what combinations have the strongest evidence for the specific clinical picture.
Call to Action
If this guide has helped clarify the options around combining depression treatments, the mental health section at PharmaHealths.com has everything you need to build on it. I’ve written detailed guides on why antidepressants stop working, the full range of options available when standard treatment has not delivered, in-depth breakdowns of TMS and ketamine therapy, and a complete explanation of common antidepressant side effects and how to manage them. All of it is written from a pharmacist’s perspective, evidence-based, clearly explained, and designed to help you walk into clinical appointments better prepared.
Disclaimer
This article is for general informational and educational purposes only and does not constitute medical advice or a recommendation to change your treatment. Combining depression treatments carries real clinical considerations and must always be assessed and supervised by a qualified healthcare professional. Never add, stop, or change any medication without first consulting your doctor, psychiatrist, or pharmacist.
References
• Cuijpers P et al. Adding psychotherapy to antidepressant medication in depression and anxiety disorders. JAMA Psychiatry. 2014. https://jamanetwork.com/
